This topic contains a solution. Click here to go to the answer

Author Question: What is NOT considered good practice when using e-mail? A. Label your e-mail in the subject line ... (Read 123 times)

tatyanajohnson

  • Hero Member
  • *****
  • Posts: 569
What is NOT considered good practice when using e-mail?
 
  A. Label your e-mail in the subject line only if the information is confidential.
  B. Keep e-mail direct and concise.
  C. End the e-mail with a clear summary, request, or direction.
  D. Review, edit, and double-check e-mail before sending.

Question 2

Which one of the following statements is true about using e-mail?
 
  A. Do not worry about the subject line; it's redundant because the recipient can
  see what the message is about my reading it.
  B. Do not send personal or sensitive information, and do not use e-mail for
  confidential correspondence.
  C. Because it's easier than using attachments, send long reports as the body of
  an email message.
  D. Because e-mails are saved in your inbox or sent messages folder, you should
  never print them.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

fffftttt

  • Sr. Member
  • ****
  • Posts: 322
Answer to Question 1

A

Answer to Question 2

B





 

Did you know?

Nearly 31 million adults in America have a total cholesterol level that is more than 240 mg per dL.

Did you know?

Liver spots have nothing whatsoever to do with the liver. They are a type of freckles commonly seen in older adults who have been out in the sun without sufficient sunscreen.

Did you know?

Fatal fungal infections may be able to resist newer antifungal drugs. Globally, fungal infections are often fatal due to the lack of access to multiple antifungals, which may be required to be utilized in combination. Single antifungals may not be enough to stop a fungal infection from causing the death of a patient.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library